J0651 Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg

Short descriptor: Inj, levothyroxine, freskabi

✓ Active HCPCS Level II 2026
Open J0651 in the app →

Look up J0651 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J0651 is the HCPCS Level II code for Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2024-07-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
levothyroxine sodium, not therapeutically equivalent to j0650
Dose / Unit
10 mcg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J0651 with the canonical source and edition:

J0651 — Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J0651

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J0651

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial